Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T13:36:01.795Z.
Calculation as of: 2026-10-06T13:36:01.795Z.
Quote observation: 2026-10-06T13:35:05.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 412370d08cb3fb7a3c2e4d636897a8ea9259835d42853a062d33098765049a4f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Canopy Growth Corporation
Market Cap
$374.16M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$369.85M
Operating Cash Flow Yield
N/A
TTM Avg
15.24%
3Y Avg
15.24%
5Y Avg
15.24%
Market Cap
$360.81M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$365.81M
Operating Cash Flow Yield
N/A
TTM Avg
3.39%
3Y Avg
3.76%
5Y Avg
5.04%
Market Cap
$383.31M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$349.38M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$348.25M
Operating Cash Flow Yield
49.99%
TTM Avg
54.62%
3Y Avg
24.22%
5Y Avg
23.43%
Market Cap
$346.05M
Operating Cash Flow Yield
N/A
TTM Avg
1.16%
3Y Avg
1.16%
5Y Avg
1.16%
Market Cap
$405.64M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Canopy Growth Corporation (CGC) | $374.16M | N/A | N/A | N/A | N/A |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $369.85M | N/A | 15.24% | 15.24% | 15.24% |
| Opus Genetics, Inc. (IRD)vs › | $360.81M | N/A | N/A | N/A | N/A |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $365.81M | N/A | 3.39% | 3.76% | 5.04% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $383.31M | N/A | N/A | N/A | N/A |
| ClearPoint Neuro, Inc. (CLPT)vs › | $349.38M | N/A | N/A | N/A | N/A |
| Embecta Corp. (EMBC)vs › | $348.25M | 49.99% | 54.62% | 24.22% | 23.43% |
| Agenus Inc. (AGEN)vs › | $346.05M | N/A | 1.16% | 1.16% | 1.16% |
| Shoulder Innovations, Inc. (SI)vs › | $405.64M | N/A | N/A | N/A | N/A |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $342.23M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
